Serum inflammatory factors in patients with idiopathic choroidal neovascularization

Ocular Immunology and Inflammation

Volumn 18, Issue 5, 2010, Pages 390-394

  Yang, Fan ^a   Dou, Hong Liang ^a   Ma, Zhizhong ^a   Li, Yu Ling ^a   Lu, Xin Rong ^a   Wang, Xin ^a   He, Ping Ping ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Complement; CRP; Idiopathic CNV; IL1 ; Immunoglobulin; TNF ; VEGF

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EXAMINATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; SUBRETINAL NEOVASCULARIZATION;

ADULT; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOLOGIC TECHNIQUES; INFLAMMATION; MALE; NEPHELOMETRY AND TURBIDIMETRY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 77956825650     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2010.483315     Document Type: Article

References (29)

1. The Age-Related Eye Disease Study Research Group. Potential public health impact of AREDS results: AREDS report no. 11. Arch Ophthalmol. 2003;121:1621-1624.
2. Maberley DAL, Hollands H, Chuo J, et al. The prevalence of low vision and blindness in Canada. Eye. 2006;20:341-346.
3. Cohen SY, Laroche A, Leguen Y, et al. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103:1241-1244.
4. Lindblom B, Andersson T. The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age. Ophthalmology. 1998;105:1816-1820.
5. Ho AC, Yannuzzi LA, Pisicano K, et al. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology. 1995;102:782-789.
6. Ruiz-Moreno JM, Montero JA, Arias L, et al. Photodynamic therapy in subfoveal and juxtafoveal idiopathic and post inflammatory choroidal neovascularization. Acta Ophthalmol Scand. 2006;84: 743-748.
7. Kumar A, Prakash G, Singh RP. Transpupillary thermotherapy for idiopathic subfoveal choroidal neovascularization. Acta Ophthalmol Scand. 2004: 82: 205-208.
8. Flaxel CJ, Owens SL, Mulholland B, et al. The use of corticosteroids for choroidal neovascularization in young patients. Eye. 1998;12: 266-272.
9. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999; 77:527-543. (Pubitemid 29426311)
10. Wang JJ, Ross RJ, Tuo J, et al. The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration: a population-based case control study. Ophthalmology. 2008;115:693-699.
11. Seddon JM, Gensler G, Milton RC, et al. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004;291:704-710. (Pubitemid 38543790)
12. Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA. 2006;103:2328-2333.
13. Tsai DC, Chamg MJ, Lee FL, et al. Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica. 2006;220:246-251.
14. Lip PL, Blann AD, Hope-Ross M, et al. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology. 2001;108:705-710.
15. Guerrin M, Moukadiri H, Chollet P, et al. Vasculotropin/ vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol. 1995;164:385-394.
16. Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relation. Am J Pathol. 1999;155:421-428.
17. Berse B, Brown LF, Van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992;3:211-220.
18. Poulsen LK, Hummelshoj L. Triggers of IgE class switching and allergy development. Ann Med. 2007;39:440-456.
19. Machida S, Fujiwara T, Murai KI, et al. Idiopathic choroidal neovascularization as an early manifestation of inflammatory chorioretinal diseases. Retina. 2008;28:703-710.
20. Grossnkilaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 2002;8:119-126.
21. Sakurai E, Anand A, Ambati BK, et al. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:3578-3585. (Pubitemid 36909798)
22. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40: 1891-1898.
23. Shi X, Semkova I, Muther P, et al. Inhibition of TNF-a reduces laser-induced choroidal neovascularization. Exp Eye Res. 2006;83:1325-1334.
24. Hangai M, He S, Hoffmann S, et al. Sequential induction of angiogenic growth factors by TNF-α in choroidal endothelial cells. J Neuroimmunol. 2006;171:45-56.
25. Bain ZM, Elner S G, Elner VM. Regulation of VEGF mRNA expression and protein secretion by TGF-β2 in human retinal pigment epithelial cells. Exp Eye Res. 2007;84: 812-822.
26. Johnson LV, Leitner WP, Staples MK, et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res. 2001;73:887-896.
27. Narayanan R, Butani V, Boyer DS, et al. Complement factor H polymorphism in age-related macular degeneration. Ophthalmology. 2007;114:1327-1331.
28. Seddon JM, George S, Rosner B, et al. Progression of agerelated macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol. 2005;123:774-782.
29. Johnson PT, Betts KE, Radeke MJ, et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroids. Proc Natl Acad Sci USA. 2006;103:17456-17461.